Avidity Biosciences, Inc. short interest in 2025
In 2025, Avidity Biosciences, Inc.'s disclosed short interest ran from 12.90% of shares outstanding on 15 Jan 2025 to 5.83% on 31 Dec 2025, a change of -7.07 percentage points. The year's high was 17.29% on 15 Sep 2025 and its low 5.83% on 31 Dec 2025, averaging 12.25% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.90 days on 30 May 2025. Full history: Avidity Biosciences, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2025 in figures
- Start of year
- 12.90% (15 Jan 2025)
- End of year
- 5.83% (31 Dec 2025)
- Change
- -7.07 pp
- High
- 17.29% (15 Sep 2025)
- Low
- 5.83% (31 Dec 2025)
- Average
- 12.25%
- Highest days to cover
- 14.90 (30 May 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 12.90% | 11.30 | |
| 31 Jan 2025 | 12.53% | 12.00 | |
| 14 Feb 2025 | 13.71% | 11.38 | |
| 28 Feb 2025 | 14.10% | 13.41 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 13.42% | 12.57 | |
| 31 Mar 2025 | 14.62% | 11.47 | |
| 15 Apr 2025 | 12.88% | 7.31 | |
| 30 Apr 2025 | 12.93% | 13.28 | |
| 15 May 2025 | 13.10% | 10.07 | 10-Q filed, results (8-K) |
| 30 May 2025 | 13.42% | 14.90 | |
| 13 Jun 2025 | 13.56% | 9.20 | |
| 30 Jun 2025 | 13.87% | 14.64 | |
| 15 Jul 2025 | 13.49% | 6.86 | |
| 31 Jul 2025 | 12.60% | 5.67 | |
| 15 Aug 2025 | 12.18% | 3.47 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 13.66% | 8.96 | |
| 15 Sep 2025 | 17.29% | 4.21 | |
| 30 Sep 2025 | 16.13% | 7.32 | |
| 15 Oct 2025 | 15.57% | 13.50 | |
| 31 Oct 2025 | 6.97% | 1.00 | |
| 14 Nov 2025 | 6.85% | 2.03 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 5.88% | 3.31 | |
| 15 Dec 2025 | 6.46% | 4.12 | |
| 31 Dec 2025 | 5.83% | 4.61 |
See also: Avidity Biosciences, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.